A Mobile Gaming App to Improve Adherence to PrEP
Launched by RHODE ISLAND HOSPITAL · Feb 27, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a mobile game called Viral Combat, designed to help young people aged 15-34 stay on track with their PrEP medication, which is used to prevent HIV infection. The trial will involve participants from clinical settings in New England and Mississippi. Researchers will first conduct interviews with healthcare workers, clinic staff, and patients to gather feedback on how to make the game better for different communities. After making adjustments based on this feedback, the game will be tested with 200 participants to see how effective it is compared to a different game that is not related to PrEP.
To be eligible for the trial, participants need to be between 15 and 34 years old, speak English, and have started or restarted their PrEP medication in the last month. They also need to be HIV negative and capable of giving consent. If you join the trial, you can expect to play the game while researchers monitor how well you stick to taking your medication. The goal is to find out if the game makes it easier for young people to use PrEP consistently, which can help in the fight against HIV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 15-34 years old
- • English speaking
- • Initiated PrEP in the last 30 days or re-initiated PrEP after not taking PrEP for at least 1 month
- • HIV negative as per clinician and clinical record
- • Able to give consent/assent and not impaired by cognitive or medical limitations as per clinical assessment.
- Exclusion Criteria:
- • None
About Rhode Island Hospital
Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Jackson, Mississippi, United States
Providence, Rhode Island, United States
Patients applied
Trial Officials
Larry K Brock, MD
Study Director
Rhode Island Hospital
Sharon Vuppula, MD
Study Director
Boston Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials